PubRank

L T Williams

Author PubWeight™ 299.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992 7.49
2 Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999 6.09
3 A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 1998 5.94
4 Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 1977 5.87
5 Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 1992 5.09
6 Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell 1989 4.86
7 PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell 1990 4.85
8 cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell 1991 4.76
9 Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993 4.67
10 A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998 4.52
11 Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science 1989 4.21
12 Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997 4.19
13 Signalling by receptor tyrosine kinases. Annu Rev Biochem 1993 4.11
14 Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 1989 3.83
15 Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol 1996 3.82
16 Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988 3.76
17 A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol 1997 3.52
18 Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 1995 3.42
19 A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol Cell Biol 1991 3.20
20 The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994 3.07
21 Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci U S A 1993 3.01
22 Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A 1992 2.89
23 An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 1994 2.80
24 Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A 2001 2.77
25 Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 1994 2.71
26 Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex. Mol Cell Biol 1990 2.71
27 c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell 1985 2.69
28 PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 2001 2.69
29 Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci U S A 1998 2.66
30 The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 1991 2.63
31 Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. J Biol Chem 1984 2.61
32 Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest 1976 2.58
33 Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. Proc Natl Acad Sci U S A 1995 2.58
34 Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci U S A 1991 2.48
35 Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Nature 1992 2.46
36 Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 1992 2.34
37 Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol 1990 2.33
38 Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. Immunopurification using a monoclonal antibody to phosphotyrosine. J Biol Chem 1984 2.33
39 Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 1993 2.32
40 Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996 2.31
41 Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J 1997 2.26
42 Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. Proc Natl Acad Sci U S A 1999 2.25
43 Activation of Raf-1 by 14-3-3 proteins. Nature 1994 2.22
44 Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd. Proc Natl Acad Sci U S A 2001 2.22
45 A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF. Nature 1988 2.13
46 Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 1977 2.13
47 Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc Natl Acad Sci U S A 1995 2.06
48 ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol 1994 2.05
49 Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr Biol 1998 2.02
50 Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 1998 2.01
51 Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci U S A 1986 2.00
52 The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor. Mol Cell Biol 1992 1.99
53 Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 1997 1.99
54 Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 1998 1.93
55 The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol 1994 1.91
56 Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding. J Biol Chem 1976 1.84
57 Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 1988 1.83
58 A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci U S A 1995 1.82
59 Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978 1.82
60 Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors. Proc Natl Acad Sci U S A 1984 1.80
61 Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding. Science 1976 1.79
62 Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J 1993 1.78
63 Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 1992 1.77
64 Processing of the platelet-derived growth factor receptor. Biosynthetic and degradation studies using anti-receptor antibodies. J Biol Chem 1987 1.76
65 Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 1996 1.71
66 Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo. J Biol Chem 1988 1.70
67 PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 1995 1.68
68 Thrombin stimulates c-sis gene expression in microvascular endothelial cells. J Biol Chem 1986 1.65
69 Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF. Cell 1993 1.60
70 Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor. Science 1991 1.59
71 Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol 1996 1.57
72 Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis. Mol Cell Biol 1989 1.54
73 Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor. Mol Cell Biol 1988 1.54
74 A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. J Biol Chem 1992 1.52
75 Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding. J Clin Invest 1978 1.51
76 Triggering signaling cascades by receptor tyrosine kinases. Trends Biochem Sci 1992 1.50
77 Pertussis toxin-sensitive pathway in the stimulation of c-myc expression and DNA synthesis by bombesin. Science 1986 1.49
78 Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding. Proc Natl Acad Sci U S A 1975 1.49
79 Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc Natl Acad Sci U S A 1997 1.48
80 Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells. Mol Cell Biol 1992 1.48
81 Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem 1996 1.46
82 Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor. J Biol Chem 1977 1.46
83 Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor. Science 1985 1.39
84 Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. J Biol Chem 1988 1.38
85 Drosophila par-1 is required for oocyte differentiation and microtubule organization. Curr Biol 2001 1.37
86 A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol Cell Biol 1993 1.36
87 Purification of the platelet-derived growth factor receptor by using an anti-phosphotyrosine antibody. Proc Natl Acad Sci U S A 1985 1.35
88 Developmentally regulated use of alternative promoters creates a novel platelet-derived growth factor receptor transcript in mouse teratocarcinoma and embryonic stem cells. Mol Cell Biol 1989 1.35
89 Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable. Proc Natl Acad Sci U S A 1982 1.34
90 Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation. J Biol Chem 1988 1.34
91 Catecholamine binding to the beta-adrenergic receptor. Proc Natl Acad Sci U S A 1977 1.34
92 Platelet-derived growth factor receptors expressed by cDNA transfection couple to a diverse group of cellular responses associated with cell proliferation. J Biol Chem 1988 1.31
93 Binding of NCK to SOS and activation of ras-dependent gene expression. Mol Cell Biol 1995 1.30
94 Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci U S A 1995 1.30
95 CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol 1998 1.29
96 Raf-1 protein kinase is important for progesterone-induced Xenopus oocyte maturation and acts downstream of mos. Mol Cell Biol 1993 1.27
97 Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta. J Biol Chem 1987 1.26
98 Functional domains of axin. Importance of the C terminus as an oligomerization domain. J Biol Chem 1999 1.24
99 Cpk is a novel class of Drosophila PtdIns 3-kinase containing a C2 domain. J Biol Chem 1996 1.22
100 Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte chemotaxis through different structural determinants. J Clin Invest 1983 1.19
101 Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs. Nucleic Acids Res 1985 1.18
102 Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells. Blood 1999 1.16
103 Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 2000 1.16
104 A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J Biol Chem 1995 1.15
105 Regulation of rabbit myometrial alpha adrenergic receptors by estrogen and progesterone. J Clin Invest 1977 1.15
106 Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding. J Biol Chem 1976 1.14
107 Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc Natl Acad Sci U S A 1997 1.13
108 Regulated expression of the platelet-derived growth factor A chain gene in microvascular endothelial cells. J Biol Chem 1987 1.12
109 The post-translational modification of ras p21 is important for Raf-1 activation. J Biol Chem 1994 1.11
110 Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase. J Biol Chem 1996 1.10
111 Platelet-derived growth factor receptor mediates activation of ras through different signaling pathways in different cell types. Mol Cell Biol 1993 1.09
112 Expression of the platelet-derived growth factor beta receptor during organogenesis and tissue differentiation in the mouse embryo. Dev Dyn 1994 1.05
113 Dominant-negative mutations of platelet-derived growth factor (PDGF) receptors. Inhibition of receptor function by ligand-dependent formation of heterodimers between PDGF alpha- and beta-receptors. J Biol Chem 1993 1.05
114 A functional soluble extracellular region of the platelet-derived growth factor (PDGF) beta-receptor antagonizes PDGF-stimulated responses. J Biol Chem 1991 1.03
115 A common PDGF receptor is activated by homodimeric A and B forms of PDGF. Science 1988 1.02
116 The fibroblast growth factor receptor is not required for herpes simplex virus type 1 infection. J Virol 1992 1.02
117 Specific binding of the calcium antagonist [3H]nitrendipine to subcellular fractions isolated from canine myocardium. Evidence for high affinity binding to ryanodine-sensitive sarcoplasmic reticulum vesicles. J Biol Chem 1983 1.01
118 Phosphatidylinositol 3-kinase is necessary and sufficient for insulin-stimulated stress fiber breakdown. Endocrinology 1996 1.00
119 Molecular mechanisms of activation and desensitization of adenylate cyclase coupled beta-adrenergic receptors. Adv Cyclic Nucleotide Res 1978 1.00
120 Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 1999 0.99
121 A v-sis oncogene protein produced in bacteria competes for platelet-derived growth factor binding to its receptor. J Biol Chem 1984 0.99
122 A naturally occurring secreted form of fibroblast growth factor (FGF) receptor 1 binds basic FGF in preference over acidic FGF. J Biol Chem 1992 0.98
123 Regulation of adenylate cyclase coupled beta-adrenergic receptors. Recent Prog Horm Res 1976 0.98
124 Platelet-derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through phosphatidylinositol 3-kinase binding sites on the receptor. Proc Natl Acad Sci U S A 1995 0.97
125 Activation of Na+/H+ exchange by platelet-derived growth factor involves phosphatidylinositol 3'-kinase and phospholipase C gamma. J Biol Chem 1994 0.96
126 Biosynthetic and glycosylation studies of cell surface platelet-derived growth factor receptors. J Biol Chem 1987 0.96
127 Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways. Blood 1995 0.95
128 Magnesium dependence of agonist binding to adenylate cyclase-coupled hormone receptors. J Biol Chem 1978 0.94
129 A desensitized state of the beta adrenergic receptor not associated with high-affinity agonist occupancy. Mol Pharmacol 1978 0.93
130 Thyroxine and propylthiouracil effects on alpha- and beta-adrenergic receptor number, ATPase activities, and sialic acid content of rat cardiac membrane vesicles. J Cardiovasc Pharmacol 1980 0.92
131 Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neurooncol 1990 0.92
132 Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J Clin Invest 1982 0.91
133 SIP/SHIP inhibits Xenopus oocyte maturation induced by insulin and phosphatidylinositol 3-kinase. Mol Cell Biol 1997 0.91
134 Well-defined growth factors promote cardiac development in axolotl mesodermal explants. Development 1991 0.89
135 Reduction of food intake and weight gain by the ob protein requires a specific secondary structure and is reversible. Mol Med 1996 0.89
136 Tyrosine 508 of the 85-kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor. Biochemistry 1994 0.88
137 Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations. Mol Pharmacol 1977 0.87
138 New steps in the Wnt/beta-catenin signal transduction pathway. Recent Prog Horm Res 2000 0.86
139 Evidence for both tyrosine kinase and G-protein-coupled pathways leading to starfish egg activation. Dev Biol 1994 0.86
140 Regulation of Raf-1-dependent signaling during early Xenopus development. Mol Cell Biol 1995 0.85
141 Dental extractions in patients with acute nonlymphocytic leukemia. J Oral Maxillofac Surg 1982 0.85
142 Human platelet-derived growth factor: structure and function. Fed Proc 1983 0.84
143 Phosphatidylinositol 3-kinase activity is important for progesterone-induced Xenopus oocyte maturation. Mol Cell Biol 1993 0.84
144 Phospholipase C gamma activation, phosphotidylinositol hydrolysis, and calcium mobilization are not required for FGF receptor-mediated chemotaxis. Cell Adhes Commun 1994 0.84
145 Signaling inositol polyphosphate-5-phosphatase. Characterization of activity and effect of GRB2 association. J Biol Chem 1997 0.84
146 Periodontal infection in patients with acute nonlymphocyte leukemia. Prevalence of acute exacerbations. Arch Intern Med 1982 0.83
147 Microbiology of acute periodontal infection in myelosuppressed cancer patients. J Clin Oncol 1987 0.83
148 Characterization of chicken protein tyrosine phosphatase alpha and its expression in the central nervous system. Brain Res Mol Brain Res 1996 0.82
149 Platelet-derived growth factor receptor inducibility is acquired immediately after translation and does not require glycosylation. J Biol Chem 1989 0.82
150 Direct activation of phospholipase C-gamma by fibroblast growth factor receptor is not required for mesoderm induction in Xenopus animal caps. Mol Cell Biol 1994 0.81
151 The sis gene and PDGF. Cancer Surv 1986 0.81
152 Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol Endocrinol 1988 0.81
153 Stimulation of paracrine and autocrine pathways of cell proliferation by platelet-derived growth factor. Clin Res 1988 0.81
154 Developmental expression of platelet-derived growth factor and its receptor in the human placenta. Mol Endocrinol 1988 0.79
155 Characterization of the interaction of Raf-1 with ras p21 or 14-3-3 protein in intact cells. FEBS Lett 1995 0.79
156 Characterization of the FGFR-3 gene and its gene product. Ann N Y Acad Sci 1991 0.79
157 Arachidonic acid and cyclic adenosine monophosphate stimulation of c-fos expression by a pathway independent of phorbol ester-sensitive protein kinase C. Mol Endocrinol 1988 0.79
158 Inhibition of mSOS-activity by binding of phosphatidylinositol 4,5-P2 to the mSOS pleckstrin homology domain. Oncogene 1998 0.78
159 Chromosomal localization of the gene for AA-type platelet-derived growth factor receptor (PDGFRA) in humans and mice. Cytogenet Cell Genet 1991 0.78
160 Oncogene-related growth factors and growth factor receptors in human malignant glioma-derived cell lines. J Neurooncol 1989 0.78
161 Cyclic AMP blocks expression of the c-sis gene in tumor cells. Oncogene Res 1989 0.77
162 Periodontal disease and oral microbial successions during myelosuppressive cancer chemotherapy. J Clin Periodontol 1989 0.77
163 Isolation and characterization of the platelet-derived growth factor beta receptor promoter. Dev Dyn 1997 0.76
164 Dental care for patients receiving chemotherapy. J Am Dent Assoc 1986 0.75
165 UCSF Research Institute: no Hughes approval. Science 1993 0.75
166 Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase. J Clin Invest 1977 0.75
167 Viability of transgenic mice expressing a platelet derived growth factor (PDGF) antagonist in plasma. J Investig Med 1996 0.75
168 Client satisfaction and weight loss outcomes of student centred dietetic outpatient clinics. Obes Res Clin Pract 2013 0.75
169 Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation. Trans Assoc Am Physicians 1988 0.75
170 Poorly-differentiated nodular lymphoma associated with the mandible. J Oral Med 1981 0.75
171 Developing dietetic positions in rural areas: what are the key lessons? Rural Remote Health 2012 0.75
172 Interactions of PDGF and FGF receptors with cytoplasmic signaling molecules. Cold Spring Harb Symp Quant Biol 1992 0.75
173 Acute periodontal infection associated with dental prostheses during cancer chemotherapy. Gerodontics 1986 0.75
174 Acute periodontal infection in myelosuppressed oncology patients: evaluation and nursing care. Cancer Nurs 1982 0.75
175 Phosphatidylinositol linkage of a truncated form of the platelet-derived growth factor receptor. J Biol Chem 1988 0.75
176 An unusual instance of leukemic infiltrate. Diagnosis and management of periapical tooth involvement. Cancer 1983 0.75
177 Molecular mechanisms of platelet-derived growth factor action. Prog Clin Biol Res 1988 0.75
178 Ras-interacting domain of RGL blocks Ras-dependent signal transduction in Xenopus oocytes. FEBS Lett 1996 0.75
179 Signal transduction by the platelet-derived growth factor receptor involves association of the receptor with cytoplasmic molecules. Clin Res 1989 0.75
180 Signaling molecules that mediate the actions of FGF. Princess Takamatsu Symp 1994 0.75
181 Identification of phosphotyrosine residues during protein sequence analysis. Pept Res 1992 0.75
182 Leukemia and dental treatment. Dent Hyg (Chic) 1981 0.75
183 Beta-adrenergic receptors: regulatory role of agonists. J Supramol Struct 1978 0.75
184 A receptor for vascular endothelial growth factor that stimulates endothelial apoptosis. Cancer Res 2001 0.75
185 Dietary intake of individuals interested in eating a healthy diet: a validated study of intake before and after dietary advice. Hum Nutr Appl Nutr 1987 0.75